News

The Phase II trial met its co-primary immunogenicity objectives regarding co-administration of Trumenba with MCV4 and Tdap vaccines. The randomized, controlled, observer-blinded Phase II trial evaluated the safety,

The Irish firm will also make additional, undisclosed, payments to Meritage based on the achievement of drug development and regulatory milestones. Shire Research and Development head Philip Vickers

In order to boost its presence in the country’s rural markets, Elder Pharmaceuticals will make the new products available in smaller sizes as well. Elder Pharmaceuticals managing director

Michael E. DeBakey Veterans Affairs Medical Center cardiologist Virani said: "Since aspirin is an over-the-counter drug, it is quite possible that some of this inappropriate use could be

This multi-year collaboration will come into effect, following the expiration of the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act. Merck Research Laboratories president Roger M. Perlmutter said:

Under the terms of consent agreement, the Swiss pharmaceutical company will divest all assets related to its BRAF and MEK inhibitor drugs to Array BioPharma to settle charges

MedImmune and NIST have inked a five-year agreement to this effect. As per the terms of the agreement, MedImmune is providing first-year funding for seven NIST postdoctoral scientists,

The company estimates the FDA decision for the sNDA in June 2015 based on the anticipated Prescription Drug User Fee Act (PDUFA) action date. Pfizer Global Innovative Pharmaceuticals

The acquisition forms a part of the company’s strategy to become a significant global biopharmaceutical company with drug discovery and clinical development capabilities for generating medicines. With this